Latham & Watkins Advises Enko in its US$70 Million Series C Financing

U · A

Unknown Author

January 24, 2026

Latham & Watkins Advises Enko in its US$70 Million Series C Financing

1 min

AI-made summary

Enko, a crop health company, has secured a US$70 million Series C funding round, increasing its total capital raised to US$140 million
The round was led by global agrochemical company Nufarm, which is expanding its partnership with Enko to introduce new products to key markets
Latham & Watkins LLP is representing Enko in the financing, with a Boston-based corporate team led by partners Kristen Grannis and Spencer Ricks, and associate Andrew Rondeau.

Enko, the crop health company, has announced a US$70 million Series C funding round, bringing the company's overall capital raised to date to US$140 million. Global agrochemical company Nufarm led the round as part of an expanded partnership to bring innovative products to their core markets. Latham & Watkins LLP represents Enko in the financing with a Boston-based corporate team led by partners Kristen Grannis and Spencer Ricks, with associate Andrew Rondeau.~~

U

Article Author